Table 1.
Overall ranking of research foci in the past 10 years.
| Rank | MeSH term | Record of occurrence in publications |
|---|---|---|
| 1 | Treatment outcome | 4,410 |
| 2 | Intestinal mucosa | 3,562 |
| 3 | Risk factors | 3,142 |
| 4 | Tumor necrosis factor-alpha | 2,967 |
| 5 | Infliximab | 2,770 |
| 6 | Severity of illness index | 2,713 |
| 7 | Mice | 2,704 |
| 8 | Gastrointestinal agents | 2,273 |
| 9 | Immunosuppressive agents | 2,228 |
| 10 | Biomarkers | 2,197 |
| 11 | Anti-inflammatory agents | 2,157 |
| 12 | Disease models, animal | 1,858 |
| 13 | Inflammation | 1,837 |
| 14 | Prognosis | 1,799 |
| 15 | Antibodies, monoclonal | 1,783 |
| 16 | Colonoscopy | 1,741 |
| 17 | Feces | 1,573 |
| 18 | Gastrointestinal microbiome | 1,477 |
| 19 | Time factors | 1,393 |
| 20 | Adalimumab | 1,389 |